ArticleFrontiers in bioengineering and biotechnology2025

Closed-system manufacturing of therapeutic NK cells using automated cell enrichment and concentration processes enables scalable, robust and cost-effective solutions.

Nina Kok et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.